DIA 2021 Global Annual Meeting

Back to Agenda

How to Avoid Shortages? Insights from the EU Executive Steering Group on Shortages – Learnings from the COVID-19 Pandemic

Session Chair(s)

Monica Dias, PharmD, PhD, MPharm, RPh

Head of Supply and Availability of Medicines and Devices, a.i.

European Medicines Agency, Netherlands

The EU Steering Group on shortage coordinated urgent actions to prevent supply disruptions within the EU during the pandemic, including regulatory flexibilities and monitoring of shortages of medicines used for COVID-19 patients.

Learning Objective : Describe how shortages of medicines are coordinated in the EU/EEA, their root causes, and contingency measures to prevent or mitigate shortages; Discuss how the European Medicines Regulatory Network (EMRN) has stepped up its efforts to prevent or mitigate the impact of shortages of medicines during the COVID-19 pandemic.

Speaker(s)

How to Avoid Shortages: Patients Point of View

Charlotte Roffiaen

France Assos Santé, France

European Policy Advisor

Avoiding Shortages During COVID-19: Lessons Learned From Community Pharmacists

Jan De Belie

Pharmaceutical Group of the European Union (PGEU), Belgium

Professional Affairs Advisor

Update

David Jauch, MBA

Fresenius Kabi Deutschland GmbH, Germany

Director - Government Affairs and CSR

Have an account?